138 related articles for article (PubMed ID: 25740678)
1. Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review.
Pezzolo E; Modena Y; Corso B; Giusti P; Gusella M
Eur J Clin Pharmacol; 2015 May; 71(5):529-39. PubMed ID: 25740678
[TBL] [Abstract][Full Text] [Related]
2. XRCC1 gene polymorphism for prediction of response and prognosis in the multimodality therapy of patients with locally advanced rectal cancer.
Grimminger PP; Brabender J; Warnecke-Eberz U; Narumiya K; Wandhöfer C; Drebber U; Bollschweiler E; Hölscher AH; Metzger R; Vallböhmer D
J Surg Res; 2010 Nov; 164(1):e61-6. PubMed ID: 20863523
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.
Dreussi E; Cecchin E; Polesel J; Canzonieri V; Agostini M; Boso C; Belluco C; Buonadonna A; Lonardi S; Bergamo F; Gagno S; De Mattia E; Pucciarelli S; De Paoli A; Toffoli G
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608007
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.
Balboa E; Duran G; Lamas MJ; Gomez-Caamaño A; Celeiro-Muñoz C; Lopez R; Carracedo A; Barros F
Pharmacogenomics; 2010 Jun; 11(6):747-61. PubMed ID: 20504250
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review of Candidate Single-nucleotide Polymorphisms as Biomarkers for Responsiveness to Neoadjuvant Chemoradiation for Rectal Cancer.
Maring ED; Tawadros PS; Steer CJ; Lee JT
Anticancer Res; 2015 Jul; 35(7):3761-6. PubMed ID: 26124319
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.
Páez D; Salazar J; Paré L; Pertriz L; Targarona E; del Rio E; Barnadas A; Marcuello E; Baiget M
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1319-27. PubMed ID: 21570215
[TBL] [Abstract][Full Text] [Related]
7. X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients.
Lamas MJ; Duran G; Gomez A; Balboa E; Anido U; Bernardez B; Rana-Diez P; Lopez R; Carracedo A; Barros F
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):138-44. PubMed ID: 21167658
[TBL] [Abstract][Full Text] [Related]
8. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
Carpinetti P; Donnard E; Bettoni F; Asprino P; Koyama F; Rozanski A; Sabbaga J; Habr-Gama A; Parmigiani RB; Galante PA; Perez RO; Camargo AA
Oncotarget; 2015 Nov; 6(35):38360-71. PubMed ID: 26451609
[TBL] [Abstract][Full Text] [Related]
9. Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer.
Conde-Muíño R; Cuadros M; Zambudio N; Segura-Jiménez I; Cano C; Palma P
Biomed Res Int; 2015; 2015():921435. PubMed ID: 26504848
[TBL] [Abstract][Full Text] [Related]
10. Predictive and prognostic biomarkers for neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Lim SH; Chua W; Henderson C; Ng W; Shin JS; Chantrill L; Asghari R; Lee CS; Spring KJ; de Souza P
Crit Rev Oncol Hematol; 2015 Oct; 96(1):67-80. PubMed ID: 26032919
[TBL] [Abstract][Full Text] [Related]
11. Acute toxicity of radiochemotherapy in rectal cancer patients: a risk particularly for carriers of the TGFB1 Pro25 variant.
Schirmer MA; Mergler CP; Rave-Fränk M; Herrmann MK; Hennies S; Gaedcke J; Conradi LC; Jo P; Beissbarth T; Hess CF; Becker H; Ghadimi M; Brockmöller J; Christiansen H; Wolff HA
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):149-57. PubMed ID: 22000747
[TBL] [Abstract][Full Text] [Related]
12. Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy.
Cecchin E; Agostini M; Pucciarelli S; De Paoli A; Canzonieri V; Sigon R; De Mattia E; Friso ML; Biason P; Visentin M; Nitti D; Toffoli G
Pharmacogenomics J; 2011 Jun; 11(3):214-26. PubMed ID: 20368715
[TBL] [Abstract][Full Text] [Related]
13. An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer.
Agostini M; Janssen KP; Kim IJ; D'Angelo E; Pizzini S; Zangrando A; Zanon C; Pastrello C; Maretto I; Digito M; Bedin C; Jurisica I; Rizzolio F; Giordano A; Bortoluzzi S; Nitti D; Pucciarelli S
Oncotarget; 2015 Oct; 6(32):32561-74. PubMed ID: 26359356
[TBL] [Abstract][Full Text] [Related]
14. Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis.
Salnikova LE; Kolobkov DS
Pharmacogenomics J; 2016 Jun; 16(3):249-65. PubMed ID: 26122021
[TBL] [Abstract][Full Text] [Related]
15. [Rectal cancer: current status of multimodal therapy--when and how?].
Gaedcke J; Liersch T; Hess C; Becker H; Rödel C; Ghadimi BM
Zentralbl Chir; 2011 Aug; 136(4):334-42. PubMed ID: 21863511
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Arrazubi V; Suárez J; Guerrero D; Gómez M; Viúdez A; Arias F; Balén E; Vera R
Colorectal Dis; 2013 Apr; 15(4):428-35. PubMed ID: 22958523
[TBL] [Abstract][Full Text] [Related]
17. Predictive response biomarkers in rectal cancer neoadjuvant treatment.
Agostini M; Crotti S; Bedin C; Cecchin E; Maretto I; D'Angelo E; Pucciarelli S; Nitti D
Front Biosci (Schol Ed); 2014 Jan; 6(1):110-9. PubMed ID: 24389265
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
19. Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.
Dayde D; Tanaka I; Jain R; Tai MC; Taguchi A
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272347
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers and Molecular Imaging as Predictors of Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
Molinari C; Matteucci F; Caroli P; Passardi A
Clin Colorectal Cancer; 2015 Dec; 14(4):227-38. PubMed ID: 26170142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
